Suppr超能文献

经 Roux-en-Y 胃旁路手术后,泡腾钾钙柠檬酸盐的钙生物利用度优于柠檬酸钙片剂。

Superior calcium bioavailability of effervescent potassium calcium citrate over tablet formulation of calcium citrate after Roux-en-Y gastric bypass.

机构信息

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical School, Dallas, Texas.

出版信息

Surg Obes Relat Dis. 2013 Sep-Oct;9(5):743-8. doi: 10.1016/j.soard.2011.11.011. Epub 2011 Dec 3.

Abstract

BACKGROUND

Calcium supplementation is commonly recommended for patients after Roux-en-Y gastric bypass to avert bone loss. To test the hypothesis that effervescent (liquid) potassium-calcium-citrate (PCC) might be more bioavailable than a tablet formulation of calcium citrate (Citracal Petite), the present study compared a single dose response of the 2 compounds. The present study was conducted at the University of Texas Southwestern Medical School at Dallas.

METHODS

A total of 15 patients who had undergone Roux-en-Y gastric bypass were included in a 2-phase, crossover, randomized study comparing the single-dose bioavailability of PCC versus Citracal Petite. After following a restricted diet for 1 week, the participants ingested either a single dose of 400 mg elemental calcium as PCC or Citracal Petite. Sequential serum and urine samples were collected for a 6-hour period after the dose and analyzed for calcium, parathyroid hormone, and acid-base parameters.

RESULTS

Compared with citracal petite, PCC significantly increased the serum calcium concentrations at 2, 3, and 4 hours after the oral load. The peak to baseline variation and increment in serum calcium (area under the curve) were significantly greater after PCC (P = .015 and P = .002, respectively). Concurrently, the baseline to nadir variation and decrement in serum parathyroid hormone (area over the curve) were significantly greater after PCC (P = .004 and P = .005, respectively). Moreover, compared with Citracal Petite, PCC caused a significantly greater increment in urinary citrate (P < .0001) and potassium (P = .0004) and a significantly lower increase in urinary ammonium (P = .045).

CONCLUSION

In patients who have undergone Roux-en-Y gastric bypass, PCC was superior to Citracal Petite in conferring bioavailable calcium and suppressing parathyroid hormone secretion. PCC also provided an alkali load.

摘要

背景

钙补充剂常用于 Roux-en-Y 胃旁路术后患者,以防止骨质流失。为了验证泡腾(液体)钾钙柠檬酸(PCC)比柠檬酸钙(Citracal Petite)片剂更具生物利用度的假设,本研究比较了这两种化合物的单次剂量反应。本研究在达拉斯的德克萨斯大学西南医学分校进行。

方法

共有 15 名接受 Roux-en-Y 胃旁路手术的患者参加了一项 2 期、交叉、随机研究,比较了 PCC 与 Citracal Petite 的单次剂量生物利用度。在遵循限制饮食 1 周后,参与者摄入 400mg 元素钙的 PCC 或 Citracal Petite 单剂量。在剂量后 6 小时内采集连续血清和尿液样本,并分析钙、甲状旁腺激素和酸碱参数。

结果

与 Citracal Petite 相比,PCC 在口服负荷后 2、3 和 4 小时显著增加血清钙浓度。PCC 后血清钙的峰基变化和增量(曲线下面积)显著更大(P =.015 和 P =.002)。同时,PCC 后血清甲状旁腺激素的基峰变化和减少(曲线面积)显著更大(P =.004 和 P =.005)。此外,与 Citracal Petite 相比,PCC 导致尿柠檬酸盐(P <.0001)和钾(P =.0004)的增加显著更大,而尿铵(P =.045)的增加显著更小。

结论

在接受 Roux-en-Y 胃旁路手术的患者中,PCC 在提供生物利用钙和抑制甲状旁腺激素分泌方面优于 Citracal Petite。PCC 还提供了碱负荷。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验